|
|
|
|
| LEADER |
01867nam a2200457 i 4500 |
| 001 |
ZAG01000542061 |
| 003 |
HR-ZaZAG |
| 005 |
20120824100106.0 |
| 007 |
ta |
| 008 |
100422s2011 ci a rm 000 0dhrv d |
| 035 |
|
|
|a (HR-ZaZAG)000542061
|
| 040 |
|
|
|a HR-ZaMFS
|b hrv
|c HR-ZaMFS
|e ppiak
|
| 041 |
0 |
|
|a hrv
|b eng
|
| 100 |
1 |
|
|a Pleško, Sanja
|
| 245 |
1 |
0 |
|a Učinak azitromicina na ekspresiju TLR-4, TNFalfa i TGFbeta u crijevnoj sluznici miševa s eksperimentalnim kolitisom :
|b disertacija /
|c Sanja Pleško.
|
| 260 |
|
|
|a Zagreb :
|b [s. n.],
|c 2011.
|
| 300 |
|
|
|a 129 str. :
|b ilustr. u bojama, graf. prikazi ;
|c 30 cm.
|
| 500 |
|
|
|a Sažetak ; Summary: The effect of azithromycin on TLR-4, TNF alpha and TGF beta expression in bowel mucosa in a murine model of experimental colitis
|
| 502 |
|
|
|a Doktorska disertacija, Medicinski fakultet Sveučilišta u Zagrebu, 2011
|
| 504 |
|
|
|a Bibliografija: str. 108-127
|
| 650 |
1 |
2 |
|a Azithromycin
|x therapeutic use
|
| 650 |
1 |
2 |
|a Inflammatory Bowel Diseases
|x chemically induced
|
| 650 |
1 |
2 |
|a Inflammatory Bowel Diseases
|x drug therapy
|
| 650 |
1 |
2 |
|a Methylprednisolone
|x therapeutic use
|
| 650 |
1 |
2 |
|a Metronidazole
|x therapeutic use
|
| 650 |
2 |
2 |
|a Animals
|
| 650 |
2 |
2 |
|a Immunohistochemistry
|
| 650 |
2 |
2 |
|a Intestinal Mucosa
|x drug effects
|
| 650 |
2 |
2 |
|a Intestinal Mucosa
|x immunology
|
| 650 |
2 |
2 |
|a Intestinal Mucosa
|x pathology
|
| 650 |
2 |
2 |
|a Mice
|
| 650 |
2 |
2 |
|a Toll-Like Receptor 4
|x metabolism
|
| 650 |
2 |
2 |
|a Transforming Growth Factor beta
|x metabolism
|
| 650 |
2 |
2 |
|a Treatment Outcome
|
| 650 |
2 |
2 |
|a Tumor Necrosis Factor-alpha
|x metabolism
|
| 945 |
0 |
|
|a Mentor: Branimir Anić ;
|b 15. 07. 2011.
|
| 946 |
|
|
|a Ocjena rada: Vando Plečko, Željko Krznarić, Drago Batinić ;
|b Obrana rada: Vando Plečko, Željko Krznarić, Drago Batinić
|
| OWN |
|
|
|a MFSNZ
|
| 852 |
|
|
|b MFS
|